$1.800
+0.531 (+29.50%)Al cierre
- Máximo
- 2.950
- Apertura
- 1.550
- Precio medio ponderado por volumen
- 2.08
- Volumen
- 41.86M
- Capitalización
- —
- Mínimo
- 1.500
- Importe
- 87.20M
- EV/EBITDA, TTM
- 0.00
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market.
Análisis de IA of PomDoctor Ltd (POM)
MantenerPomDoctor Ltd is currently not a strong buy due to significant financial challenges, despite a recent price surge. The stock closed at 1.17, down 42.36% yesterday, and has a negative forward P/E ratio, indicating ongoing losses. The recent 5-day change of +85.21% suggests volatility, but the year-to-date change of -80.06% raises concerns about long-term stability. The main risk is the company's current ratio of 0.35, indicating potential liquidity issues.
Métricas de valoración
Cronología de eventos
Noticias
8.510-19PRnewswirePomdoctor Terminates ADR Program, Lists on Nasdaq
- 8.510-12PRnewswire
Pomdoctor Advances Predictive Healthcare Transformation
- 8.510-09PRnewswire
Pomdoctor Faces Nasdaq Delisting Risk Due to Low Share Price
- 7.509-30PRnewswire
Pomdoctor Advances AI Chronic Disease Management System
7.509-30NewsfilterPomdoctor Advances AI Chronic Disease Management System
Preguntas frecuentes sobre POM, respondidas por Alphio AI
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector.
PomDoctor Ltd is currently not a strong buy due to significant financial challenges, despite a recent price surge. The stock closed at 1.17, down 42.36% yesterday, and has a negative forward P/E ratio, indicating ongoing losses. The recent 5-day change of +85.21% suggests volatility, but the year-to-date change of -80.06% raises concerns about long-term stability. The main risk is the company's current ratio of 0.35, indicating potential liquidity issues.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.